Immunization, measles in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Immunization, measles was 94.4% in 2024. ▲ Rising
Immunization, measles in Europe & Central Asia (excluding high income), 1992–2024
Source: World Health Organization (WHO). Measured in % of children ages 12-23 months.
Analysis
Europe & Central Asia (excluding high income) recorded 94.4% for immunization, measles in 2024.
The figure is down 0.7% on the previous year and up 4.4% over ten years.
Over the whole period, immunization, measles in Europe & Central Asia (excluding high income) peaked at 96.0% in 2019 and was at its lowest, 79.8%, in 1992.
That places Europe & Central Asia (excluding high income) 5th out of 47 groups with data for 2024, putting it in the top 10%.
The long-run direction has been consistently rising across the 33 years of available data.
Immunization, measles in Europe & Central Asia (excluding high income), year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1992 | 79.8% | — |
| 1993 | 79.9% | +0.1% |
| 1994 | 80.2% | +0.4% |
| 1995 | 80.4% | +0.2% |
| 1996 | 83.7% | +4.1% |
| 1997 | 87.7% | +4.8% |
| 1998 | 88.0% | +0.4% |
| 1999 | 88.5% | +0.6% |
| 2000 | 91.4% | +3.2% |
| 2001 | 93.0% | +1.8% |
| 2002 | 89.2% | -4.1% |
| 2003 | 87.0% | -2.5% |
| 2004 | 89.7% | +3.1% |
| 2005 | 93.2% | +3.9% |
| 2006 | 95.4% | +2.3% |
| 2007 | 95.4% | +0.0% |
| 2008 | 95.5% | +0.1% |
| 2009 | 92.8% | -2.8% |
| 2010 | 91.4% | -1.5% |
| 2011 | 93.4% | +2.2% |
| 2012 | 93.9% | +0.5% |
| 2013 | 94.7% | +0.8% |
| 2014 | 90.4% | -4.5% |
| 2015 | 91.7% | +1.4% |
| 2016 | 90.4% | -1.5% |
| 2017 | 94.8% | +4.9% |
| 2018 | 94.9% | +0.1% |
| 2019 | 96.0% | +1.1% |
| 2020 | 92.8% | -3.3% |
| 2021 | 93.9% | +1.2% |
| 2022 | 93.3% | -0.7% |
| 2023 | 95.0% | +1.9% |
| 2024 | 94.4% | -0.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 83.5% | 79.8% | 88.5% | 8 |
| 2000s | 92.3% | 87.0% | 95.5% | 10 |
| 2010s | 93.1% | 90.4% | 96.0% | 10 |
| 2020s | 93.9% | 92.8% | 95.0% | 5 |
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is immunization, measles in Europe & Central Asia (excluding high income)?
- Immunization, measles in Europe & Central Asia (excluding high income) was 94.4% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, measles recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 96.0% in 2019.
- What is the lowest immunization, measles recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 79.8% in 1992.
- How does Europe & Central Asia (excluding high income) rank for immunization, measles?
- Europe & Central Asia (excluding high income) ranks 5th out of 47 groups with data for 2024.
- Is immunization, measles rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is up 4.4%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, measles (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.